ES2194907T3 - Utilizacion de la espiramicina en desordenes gastro-intestinales debido al h.pylori. - Google Patents
Utilizacion de la espiramicina en desordenes gastro-intestinales debido al h.pylori.Info
- Publication number
- ES2194907T3 ES2194907T3 ES95918047T ES95918047T ES2194907T3 ES 2194907 T3 ES2194907 T3 ES 2194907T3 ES 95918047 T ES95918047 T ES 95918047T ES 95918047 T ES95918047 T ES 95918047T ES 2194907 T3 ES2194907 T3 ES 2194907T3
- Authority
- ES
- Spain
- Prior art keywords
- spiramycin
- pct
- gastro
- pylori
- disorders due
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
UTILIZACION DE LA ESPIRAMICINA EVENTUALMENTE EN ASOCIACION CON EL METRONIDAZOL PARA LA PREPARACION DE UN MEDICAMENTO DESTINADO A LA PREVENCION DE LOS TRASTORNOS GASTROINTESTINALES EN LOS QUE INTERVIENE HELICOBACTER PYROLI.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9404952A FR2718965B1 (fr) | 1994-04-25 | 1994-04-25 | Nouvelle application thérapeutique de la spiramycine. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2194907T3 true ES2194907T3 (es) | 2003-12-01 |
Family
ID=9462476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95918047T Expired - Lifetime ES2194907T3 (es) | 1994-04-25 | 1995-04-24 | Utilizacion de la espiramicina en desordenes gastro-intestinales debido al h.pylori. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6162792A (es) |
EP (1) | EP0758245B1 (es) |
JP (2) | JP3937448B2 (es) |
KR (1) | KR970702054A (es) |
CN (1) | CN1147204A (es) |
AT (1) | ATE234619T1 (es) |
AU (1) | AU2412795A (es) |
BR (1) | BR9507848A (es) |
CA (1) | CA2188697A1 (es) |
DE (1) | DE69529981T2 (es) |
DK (1) | DK0758245T3 (es) |
ES (1) | ES2194907T3 (es) |
FR (1) | FR2718965B1 (es) |
NO (1) | NO311285B1 (es) |
PT (1) | PT758245E (es) |
WO (1) | WO1995028943A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN190017B (es) | 1999-01-25 | 2003-05-31 | Panacea Biotech Ltd | |
US6576625B2 (en) | 2001-03-16 | 2003-06-10 | Panacea Biotic Limited | Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0375068A1 (en) * | 1988-12-23 | 1990-06-27 | Gist-Brocades N.V. | Combining bismuth compounds and tetracyclines |
-
1994
- 1994-04-25 FR FR9404952A patent/FR2718965B1/fr not_active Expired - Lifetime
-
1995
- 1995-04-24 EP EP95918047A patent/EP0758245B1/fr not_active Expired - Lifetime
- 1995-04-24 CN CN95192781A patent/CN1147204A/zh active Pending
- 1995-04-24 US US08/727,466 patent/US6162792A/en not_active Expired - Lifetime
- 1995-04-24 KR KR1019960705982A patent/KR970702054A/ko not_active Application Discontinuation
- 1995-04-24 BR BR9507848A patent/BR9507848A/pt not_active Application Discontinuation
- 1995-04-24 PT PT95918047T patent/PT758245E/pt unknown
- 1995-04-24 DK DK95918047T patent/DK0758245T3/da active
- 1995-04-24 AU AU24127/95A patent/AU2412795A/en not_active Abandoned
- 1995-04-24 ES ES95918047T patent/ES2194907T3/es not_active Expired - Lifetime
- 1995-04-24 WO PCT/FR1995/000533 patent/WO1995028943A1/fr active IP Right Grant
- 1995-04-24 AT AT95918047T patent/ATE234619T1/de active
- 1995-04-24 JP JP52740895A patent/JP3937448B2/ja not_active Expired - Lifetime
- 1995-04-24 CA CA002188697A patent/CA2188697A1/fr not_active Abandoned
- 1995-04-24 DE DE69529981T patent/DE69529981T2/de not_active Expired - Lifetime
-
1996
- 1996-10-07 NO NO19964252A patent/NO311285B1/no not_active IP Right Cessation
-
2007
- 2007-01-12 JP JP2007004854A patent/JP2007091761A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1147204A (zh) | 1997-04-09 |
CA2188697A1 (fr) | 1995-11-02 |
JP3937448B2 (ja) | 2007-06-27 |
EP0758245B1 (fr) | 2003-03-19 |
US6162792A (en) | 2000-12-19 |
DE69529981D1 (de) | 2003-04-24 |
PT758245E (pt) | 2003-08-29 |
NO964252D0 (no) | 1996-10-07 |
JP2007091761A (ja) | 2007-04-12 |
DE69529981T2 (de) | 2003-12-04 |
JPH09512262A (ja) | 1997-12-09 |
EP0758245A1 (fr) | 1997-02-19 |
DK0758245T3 (da) | 2003-07-07 |
BR9507848A (pt) | 1997-09-16 |
FR2718965B1 (fr) | 1996-05-24 |
NO964252L (no) | 1996-10-07 |
WO1995028943A1 (fr) | 1995-11-02 |
NO311285B1 (no) | 2001-11-12 |
AU2412795A (en) | 1995-11-16 |
ATE234619T1 (de) | 2003-04-15 |
FR2718965A1 (fr) | 1995-10-27 |
KR970702054A (ko) | 1997-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69940769D1 (de) | Orale flüssige zusammensetzungen | |
BG101118A (en) | Therapeutical compounds | |
IS4187A (is) | Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun | |
BG104877A (en) | N-substituted anminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders | |
IT1282353B1 (it) | Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione | |
IL112667A0 (en) | 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them | |
BG105534A (en) | 5ht1 means and method for the treatment of migraine | |
IL94459A0 (en) | Pharmaceutical form and process for the preparation thereof | |
EP0119161A3 (en) | Benzazoquinone and benzazoninone derivatives, process for their preparation, their pharmaceutical preparations as well as their therapeutic use | |
NZ331683A (en) | New indole and indazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
DK1207870T3 (da) | Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
IL113024A (en) | Quinazolinyl-amino derivatives having alpha-antagonist activity their preparation and pharmaceutical compositions comprising them | |
DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
EP0281070A3 (en) | Pharmaceutical composition for the treatment of cancer | |
DK0748314T3 (da) | Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
NZ294878A (en) | Water soluble derivatives of epipodophyllotoxin and medicaments | |
ES2194907T3 (es) | Utilizacion de la espiramicina en desordenes gastro-intestinales debido al h.pylori. | |
HUT77868A (hu) | Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra | |
UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
FR2724933B1 (es) | ||
IL122659A (en) | Pharmaceutical compositions for the treatment of dyspeptic symptoms comprising angiotensin ii type receptor antagonists | |
SE8402199L (sv) | Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist | |
MX9802809A (es) | Ureasa para el tratamiento de infecciones de helicobacter pylori. | |
RU98114982A (ru) | Состав, содержащий диосгенин |